Search

everythinglearnresearchcommunity

for

Search:↓

Croton tiglium application significantly improved hair regrowth in alopecia areata patients.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Injectable Platelet-Rich Fibrin (I-PRF) showed positive results for treating hair loss, skin texture, wrinkles, and wounds.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Some migraine sufferers had no more headaches after getting a hair transplant.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Platelet-rich plasma (PRP) was found not effective in treating male-patterned hair loss.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Platelet-Rich Plasma treatment helps hair regrowth in people with mild Alopecia Areata, improving their quality of life with minimal side effects.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

PRP therapy with a derma roller is a safe and effective treatment for female hair loss.

Trichoscopy helps diagnose and monitor hair loss, showing different signs at various stages of hair thinning.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

The conclusion is that a safe donor area for hair transplants varies and should be chosen based on individual factors like race, future hair loss, family history, and specific thinning patterns.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Using 10% topical minoxidil, oral finasteride, and microneedling together can effectively treat Male Pattern Baldness with high patient satisfaction and no major side effects.

Beard hair can be used for hair transplants in severe alopecia cases, with minimal complications and good results.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

CHOP chemotherapy causes many side effects but is generally well tolerated.